Literature DB >> 8182034

Peptide substrate cleavage specificity of the human cytomegalovirus protease.

V V Sardana1, J A Wolfgang, C A Veloski, W J Long, K LeGrow, B Wolanski, E A Emini, R L LaFemina.   

Abstract

The human cytomegalovirus UL80 gene encodes an 80-kDa precursor polyprotein whose N-terminal 256-amino acid domain is a protease. This enzyme cleaves a specific peptide bond that results in its own release from the precursor, as well as a peptide bond near the C terminus of the viral assembly protein. The latter cleavage is apparently required for encapsidation of the viral genomic DNA and maturation of the viral capsid. A series of peptide substrates, representing the assembly protein cleavage site, was used to study the enzyme's substrate requirements and specificity. It was found that efficient cleavage minimally required the amino acid residues spanning the P4 to P4' positions. Substitution at any of these residues adversely affected the reaction. Conservation of the hydrophobic residues at P3 and P4 was essential. In addition, cleavage of a peptide representing the protease domain release site was reduced almost 100-fold relative to cleavage of the assembly protein maturation site peptide substrate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182034

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

Authors:  R Zhang; J Durkin; W T Windsor; C McNemar; L Ramanathan; H V Le
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.

Authors:  E Scarselli; A Urbani; A Sbardellati; L Tomei; R De Francesco; C Traboni
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Sequential autoprocessing of Marek's disease herpesvirus protease differs from that of other herpesviruses.

Authors:  S Laurent; C Blondeau; M Belghazi; S Remy; E Esnault; P Rasschaert; D Rasschaert
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Analysis and characterization of the complete genome of tupaia (tree shrew) herpesvirus.

Authors:  U Bahr; G Darai
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.

Authors:  R L LaFemina; K Bakshi; W J Long; B Pramanik; C A Veloski; B S Wolanski; A I Marcy; D J Hazuda
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.

Authors:  Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.

Authors:  C Wirblich; M Sibilia; M B Boniotti; C Rossi; H J Thiel; G Meyers
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Cloning, expression and characterization of the proteinase from human herpesvirus 6.

Authors:  N J Tigue; P J Matharu; N A Roberts; J S Mills; J Kay; R Jupp
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Cytomegalovirus protein substrates are not cleaved by the herpes simplex virus type 1 proteinase.

Authors:  A R Welch; E C Villarreal; W Gibson
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.